Day One Biopharmaceuticals (DAWN) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

DAWN is expected to report earnings to fall 220.24% to -45 cents per share on March 10

Day One Biopharmaceuticals DAWN Stock Earnings Reports

Q4'24

Est.

$-0.46

Q3'24

Beat

by $0.70

Q2'24

Beat

by $0.70

Q1'24

Missed

by $0.07

Q4'23

Missed

by $0.06

The last earnings report on October 30 showed earnings per share of 37 cents, beating the estimate of -31 cents. With 784.66K shares outstanding, the current market capitalization sits at 1.29B.

View a ticker or compare two or three

Compare

DAWN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DAWN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DAWN (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2000 Sierra Point Parkway

Phone

+1 650 484-0899

Employees

155

Web

https://www.dayonebio.com